Usually, the risk of the general population developing breast cancer by age 74 is 5% [29, 30], but for individuals with Lynch syndrome, by age 70, the risk increases to 11%, 13%, 11%, and 8% with the MLH1, MSH2, MSH6, and PMS2 pathogenic variants, respectively [20]. This evidence concerns the gene PMS2 and breast carcinoma.